More on the Licensed WNV Treatment
Novartis Animal Vaccines announced Aug. 19 the conditional licensing and availability of the only antibody product approved by the USDA to help control disease caused by West Nile virus (WNV) in equids. This product helps an exposed animal by increasing the antibody level in the circulatory system, which enhances an animal’s ability to neutralize virus already in the blood.
For a
- Topics: Article
Novartis Animal Vaccines announced Aug. 19 the conditional licensing and availability of the only antibody product approved by the USDA to help control disease caused by West Nile virus (WNV) in equids. This product helps an exposed animal by increasing the antibody level in the circulatory system, which enhances an animal’s ability to neutralize virus already in the blood.
For a product to get USDA conditional approval, the company must show that the product is safe, pure, and that there’s reasonable expectation of efficacy. West Nile Virus Antibody is a prescription antiserum product, administered intravenously by a licensed veterinarian. (An antibody product that is currently used by veterinarians to treat clinical signs for WNV, but is not labeled for this use, is HiGamm-Equi; see article
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com. Already have an account?Create a free account with TheHorse.com to view this content.
Start your free account today!
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with
